xml version="1.0" encoding="UTF-8"?


L\_2019324EN.01008001.xml


| | | | |
| --- | --- | --- | --- |
| 13.12.2019 | EN | Official Journal of the European Union | L 324/80 |

---

Corrigendum to Commission Regulation (EU) 2019/1966 of 27 November 2019 amending and correcting Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products

(Official Journal of the European Union L 307 of 28 November 2019)

On page 19, Annex I and Annex II are replaced as follows:

‘ANNEX I

(1)

Annex II to Regulation (EC) No 1223/2009 is amended as follows:

The following entries are added:

| | | | |
| --- | --- | --- | --- |
| Reference number | Substance identification | | |
| Chemical name/INN | CAS number | EC number |
| a | b | c | d |
| “1612 | Phosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)methyl]-O,O-dimethyl phosphorodithioate; O,O-dimethyl-S-phthalimidomethyl phosphorodithioate | 732-11-6 | 211-987-4 |
| 1613 | Potassium permanganate | 7722-64-7 | 231-760-3 |
| 1614 | 2-Benzyl-2-dimethylamino-4′- morpholinobutyrophenone | 119313-12-1 | 404-360-3 |
| 1615 | Quizalofop-p-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2- yloxy)phenyloxy]propionate | 200509-41-7 | 414-200-4 |
| 1616 | Propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazole | 60207-90-1 | 262-104-4 |
| 1617 | Pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate | 243973-20-8 | 635-361-9 |
| 1618 | Tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate | 7696-12-0 | 231-711-6 |
| 1619 | (1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylate | 1166-46-7 | 214-619-0 |
| 1620 | Spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate | 148477-71-8 | 604-636-5 |
| 1621 | Reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamine | 897393-42-9 | 447-920-2 |
| 1622 | 1-Vinylimidazole | 1072-63-5 | 214-012-0 |
| 1623 | Amisulbrom (ISO)3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide | 348635-87-0 | 672-776-4” |

(2)

Annex III to Regulation (EC) No 1223/2009 is amended as follows:

Entry 98 is replaced by the following:

| | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| “98 | Benzoic acid, 2-hydroxy-[(\*1)](#ntr*1-L_2019324EN.01008002-E0001) | Salicylic acid | 69-72-7 | 200-712-3 | | | | | --- | --- | | (a) | Rinse-off hair products | | | | | | --- | --- | | (a) | 3,0 % | | Not to be used in preparations for children under 3 years of age. | Not to be used for children under 3 years of age[(\*2)](#ntr*2-L_2019324EN.01008002-E0002) |
| | | | | --- | --- | | (b) | Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant | | | | | | --- | --- | | (b) | 2,0 % | | Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. | |
| Not to be used in oral products. |
| For purposes other than inhibiting the development of micro-organisms in the product. This purpose has to be apparent from the presentation of the product. |

(3)

Annex V to Regulation (EC) No 1223/2009 is amended as follows:

Entry 3 is replaced by the following:

| | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Reference number | Substance Identification | | | | Conditions | | | Wording of conditions of use and warnings |
| Chemical name/INN | Name of Common Ingredients Glossary | CAS number | EC number | Product type, Body parts | Maximum concentration in ready for use preparation | Other | |
| a | b | c | d | e | f | g | h | i |
| “3 | Salicylic acid[(\*3)](#ntr*3-L_2019324EN.01008002-E0003) and its salts | Salicylic acid | 69-72-7 | 200-712-3 | | 0,5 % (acid) | Not to be used in products for children under 3 years of age. | Not to be used for children under 3 years of age[(\*4)](#ntr*4-L_2019324EN.01008002-E0004) |
| Not to be used in oral products. |
| Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. |
| Calcium salicylate, magnesium salicylate, MEA- salicylate, sodium salicylate, potassium salicylate, TEA- salicylate | 824-35-1, 18917-89-0, 59866- 70-5, 54-21-7, 578-36-9, 2174-16-5 | 212-525-4, 242-669-3, 261-963-2, 200-198-0, 209-421-6, 218-531-3 | | 0,5 % (acid) | Not to be used in products for children under 3 years of age, except for shampoos. | Not to be used for children under 3 years of age[(\*5)](#ntr*5-L_2019324EN.01008002-E0005) |

‘ANNEX II

(1)

Annex II to Regulation (EC) No 1223/2009 is corrected as follows:

| | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (a) | entry 395 is replaced by the following: | | | | | | --- | --- | --- | --- | | Reference number | Substance identification | | | | Chemical name/INN | CAS number | EC number | | “395 | Hydroxy-8-quinoline and its sulphate bis(8-hydroxyquinolinium) sulphate, except for the uses of the sulphate provided for in entry 51 of Annex III | 148-24-3 134-31-6 | 205-711-1 205-137-1” | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (b) | entry 1396 is replaced by the following: | | | | | | --- | --- | --- | --- | | Reference number | Substance identification | | | | Chemical name/INN | CAS number | EC number | | a | b | c | d | | “1396 | Borates, tetraborates, octaborates and boric acid salts and esters, including: | | | | Disodium octaborate anhydrous [1] | 12008-41-2 [1] | 234-541-0 [1] | | Disodium octaborate tetrahydrate [2] | 12280-03-4 [2] | 234-541-0 [2] | | 2-Aminoethanol, monoester with boric acid [3] | 10377-81-8 [3] | 233-829-3 [3] | | 2-Hydroxypropyl ammonium dihydrogen orthoborate [4] | 68003-13-4 [4] | 268-109-8 [4] | | Potassium borate, boric acid potassium salt [5] | 12712-38-8 [5] | 603-184-6 [5] | | Trioctyldodecyl borate [6] | - [6] | - [6] | | Zinc borate [7] | 1332-07-6 [7] | 215-566-6 [7] | | Sodium borate, disodium tetraborate anhydrous; boric acid, sodium salt [8] | 1330-43-4 [8] | 215-540-4 [8] | | Tetraboron disodium heptaoxide, hydrate [9] | 12267-73-1 [9] | 235-541-3 [9] | | Orthoboric acid, sodium salt [10] | 13840-56-7 [10] | 237-560-2 [10] | | Disodium tetraborate decahydrate; borax decahydrate [11] | 1303-96-4 [11] | 215-540-4 [11] | | Disodium tetraborate pentahydrate; borax pentahydrate [12] | 12179-04-3 [12] | 215-540-4 [12]” | |

| | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (c) | entry 1507 is replaced by the following: | | | | | | --- | --- | --- | --- | | Reference number | Substance identification | | | | Chemical name/INN | CAS number | EC number | | “1507 | Diaminotoluene, methyl-phenylenediamine, technical product-reaction mass of [4-methyl-m-phenylenediamine and 2-methyl-m-phenylenediamine] | – | –” | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (d) | the following entries are added: | | | | | | --- | --- | --- | --- | | Reference number | Substance identification | | | | Chemical name/INN | CAS number | EC number | | a | b | c | d | | “1624 | Pirimicarb (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamate | 23103-98-2 | 245-430-1 | | 1625 | 1,2-Dichloropropane; propylene dichloride | 78-87-5 | 201-152-2 | | 1626 | Phenol, dodecyl-, branched [1] | 121158-58-5 [1] | 310-154-3 [1] | | Phenol, 2-dodecyl-, branched [2] | 1801269-80-6 [2] | - [2] | | Phenol, 3-dodecyl-, branched [3] | 1801269-77-1 [3] | - [3] | | Phenol, 4-dodecyl-, branched [4] | 210555-94-5 [4] | 640-104-9 [4] | | Phenol, (tetrapropenyl) derivatives [5] | 74499-35-7 [5] | 616-100-8 [5] | | 1627 | Coumatetralyl (ISO); 4- hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl) coumarin | 5836-29-3 | 227-424-0 | | 1628 | Difenacoum (ISO); 3-(3- biphenyl-4-yl-1,2,3,4- tetrahydro-1-naphthyl)- 4-hydroxycoumarin | 56073-07-5 | 259-978-4 | | 1629 | Brodifacoum (ISO); 4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin | 56073-10-0 | 259-980-5 | | 1630 | Flocoumafen (ISO); reaction mass of: cis-4- hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin | 90035-08-8 | 421-960-0 | | 1631 | Acetochlor (ISO); 2- chloro-N-(ethoxymethyl)-N-(2-ethyl-6- methylphenyl)acetamide | 34256-82-1 | 251-899-3 | | 1632 | e-Glass microfibres of representative composition | - | - | | 1633 | Glass microfibres of representative composition | - | - | | 1634 | Bromadiolone (ISO); 3- [3-(4′-bromobiphenyl- 4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy- 2H-chromen-2-one | 28772-56-7 | 249-205-9 | | 1635 | Difethialone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]- 4-hydroxy-2H-1-benzothiopyran-2-one | 104653-34-1 | 600-594-7 | | 1636 | Perfluorononan-1-oic acid [1] | 375-95-1 [1] | 206-801-3 [1] | | and its sodium [2] | 21049-39-8 [2] | - [2] | | and ammonium [3] salts | 4149-60-4 [3] | - [3] | | 1637 | Dicyclohexyl phthalate | 84-61-7 | 201-545-9 | | 1638 | 3,7-Dimethylocta-2,6- dienenitrile | 5146-66-7 | 225-918-0 | | 1639 | Bupirimate (ISO); 5-butyl-2-ethylamino-6- methylpyrimidin-4-yl dimethylsulfamate | 41483-43-6 | 255-391-2 | | 1640 | Triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1- (1H-imidazol-1-yl)-2- propoxyethanimine | 68694-11-1 | 604-708-8 | | 1641 | tert-Butyl hydroperoxide | 75-91-2 | 200-915-7” | |

(2)

Annex III to Regulation (EC) No 1223/2009 is corrected as follows:

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (a) | entry 9 is replaced by the following: | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Ref No. | Substance identification | | | | Restrictions | | | Wording of conditions of use and warnings | | Chemical name/INN | Name of Common Ingredients Glossary | CAS number | EC number | Product type, body parts | Maximum concentration in ready for use preparation | Other | | | a | b | c | d | e | f | g | h | i | | “9 | Methylphenylenediamines, their N- substituted derivatives and their salts (1), with the exception of the substance listed under reference numbers 9 a and 9 b of this Annex and the substances listed under reference numbers 364, 413, 1144, 1310, 1313 and 1507 of Annex II | | | | Hair dye substance in oxidative hair dye products | | | | | | --- | --- | | (a) | General use | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | (a) | To be printed on the label: The mixing ratio. “ Image 1 Hair colourants can cause severe allergic reactions. Read and follow instructions. This product is not intended for use on persons under the age of 16. Temporary “black henna” tattoos may increase your risk of allergy. Do not colour your hair if: | | | | --- | --- | | — | you have a rash on your face or sensitive, irritated and damaged scalp, | | | | | --- | --- | | — | you have ever experienced any reaction after colouring your hair, | | | | | --- | --- | | — | you have experienced a reaction to a temporary “black henna” tattoo in the past. | Contains phenylenediamines (toluenediamines). Do not use to dye eyelashes or eyebrows.” | | | | | | | --- | --- | | (b) | Professional use | | | | | | --- | --- | | (b) | To be printed on the label: | | | For (a) and (b): After mixing under oxidative conditions the maximum concentration applied to hair must not exceed 5 % calculated as free base | The mixing ratio. “For professional use only. Hair colourants can cause severe allergic reactions. Read and follow instructions. This product is not intended for use on persons under the age of 16. Temporary “black henna” tattoos may increase your risk of allergy. Do not colour your hair if: | | | | --- | --- | | — | you have a rash on your face or sensitive, irritated and damaged scalp, | | | | | --- | --- | | — | you have ever experienced any reaction after colouring your hair, | | | | | --- | --- | | — | you have experienced a reaction to a temporary “black henna” tattoo in the past. | Contains phenylenediamines (toluenediamines). Wear suitable gloves.”” | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (b) | the following entry is added: | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Reference number | Substance identification | | | | Restrictions | | | Wording of conditions of use and warnings | | Chemical name/INN | Name of Common Ingredients Glossary | CAS number | EC number | Product type, body parts | Maximum concentration in ready for use preparation | Other | | a | b | c | d | e | f | g | h | i | | “51 | Bis(8-hydroxyquinolinium) sulphate | Oxyqui-noline sulphate | 134-31-6 | 205-137-1 | Stabilizer for hydrogen peroxide in rinse-off hair products | (0,3 % as base) | | | | Stabilizer for hydrogen peroxide in leave-on hair products | (0,03 % as base)” | |

’

---

[(\*1)](#ntc*1-L_2019324EN.01008002-E0001)  For use as a preservative see Annex V, No 3.

[(\*2)](#ntc*2-L_2019324EN.01008002-E0002)  Solely for products which might be used for children under 3 years of age.”

[(\*3)](#ntc*3-L_2019324EN.01008002-E0003)  For uses other than preservative, see Annex III, No 98.

[(\*4)](#ntc*4-L_2019324EN.01008002-E0004)  Solely for products which might be used for children under 3 years of age

[(\*5)](#ntc*5-L_2019324EN.01008002-E0005)  Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.”

---